Evidence map›Paper›PMID 20358245›Full record

ArticleInfection2010

An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients.

T Mann, D Ben-David, A Zlotkin, D Shachar, N Keller, A Toren, A Nagler, G Smollan, A Barzilai, G Rahav

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Infection, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Colony morphotype variation inJournal of bacteriology · 2025
    Review
  6. Article
  7. Article
  8. Clinical microbiology reviews · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Epidemiology of infections in cancer patients.Cancer treatment and research · 2014
    Review
  13. Emergence of Burkholderia cepacia in Honolulu: a case of nursing home-acquired B. cepacia sepsis.Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health · 2013
    Article
  14. Article
  15. Burkholderia vaccines: are we moving forward?Frontiers in cellular and infection microbiology · 2013
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

T MannInfectious Diseases Unit, Sheba Medical Center, 52621, Tel-Hashomer, Israel.
D Ben-David
A Zlotkin
D Shachar
N Keller
A Toren
A Nagler
G Smollan
A Barzilai
G Rahav
Sheba Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBurkholderia cepacia is a common environmental bacterium that is resistant to disinfectants, and therefore is often encountered as a hospital-acquired pathogen. We describe an outbreak of B. cenocepacia bacteremia among hospitalized oncology patients.

methodsA matched case-control study and an extensive environmental investigation were conducted. Species were identified by RFLP of the amplified recA gene. DNA was fingerprinted by pulsed-field gel electrophoresis (PFGE).

resultsBetween November 2005 and September 2006, B. cenocepacia bacteremia developed in 17 patients with underlying malignancy of whom 14 had tunneled central venous catheters. All patients had fever and chills which subsided following removal of the central catheter and administration of ceftazidime. Extensive epidemiological investigation could not find a common source for the outbreak. Patients were hospitalized in three different buildings with different health care personnel. Medications were prepared in different sites by different personnel. A multivariate analysis demonstrated that the independent risk factors for developing nosocomial B. cenocepacia bacteremia were hospitalization at the center for long-term support (OR 28.8; 95% CI 1.83-453.4) and reduced use of antibiotics during the last month (OR 0.07; 95% CI 0.01-0.40). All isolates had identical antimicrobial susceptibility; PFGE indicated that a complex of closely related strains was involved in the outbreak. All isolates were identified as B. cenocepacia, known to infect cystic fibrosis patients. Strict infection control measures terminated the outbreak.

conclusionsB. cenocepacia is an emerging nosocomial pathogen among oncology patients.

Indexed as

Disease OutbreaksImmunocompromised HostAdolescentAdultAgedBacteremiaBacterial ProteinsBurkholderiaBurkholderia InfectionsCase-Control StudiesChildChild, PreschoolChi-Square DistributionElectrophoresis, Gel, Pulsed-FieldFemaleHospital UnitsBacterial ProteinsRec A Recombinases

Identifiers

PMID20358245
OpenAlexW1996614254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.